Prevalence and Antibiotic Susceptibility Pattern of Staphylococcus Aureus in Clinical Specimens by O., OPERE, Bolanle et al.
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol 10, 2013 
 
1 
Prevalence and Antibiotic Susceptibility Pattern of 
Staphylococcus Aureus in Clinical Specimens 
 
1*OPERE, Bolanle O., 1FASHOLA, Muibat O., 2ADESIDA, Solayide,  
3SMITH, Stella I. , 1ADEBIYI, Oluwaseun A. 
1. Department of Microbiology, Lagos State University, Ojo-Lagos. 
2. Department of Microbiology, University of Lagos, Akoka-Yaba. 
3.  Molecular Biology and Genetics Division, NIMR, Yaba, Lagos. 
* e-mail address of Corresponding Author: bolanleopere@yahoo.com 
 
Abstract 
The present study was carried out to determine the prevalence of Staphylococcus aureus in clinical samples and 
their susceptibility pattern to antibiotics. Standard microbiological and biochemical methods were used to screen 
155 clinical specimens comprising of sputum, wound, urine and high vaginal swabs for S .aureus. Twenty eight 
(28) isolates was obtained from these samples. Antibiotic susceptibility results shows high percentage of 
sensitivity to gentamicin (89%,) azithromycin (89%), pefloxacin (79%)  followed by erythromycin (68%) 
ciprofloxacin (61%) streptomycin (61%)and sparfloxacin (54%). A high resistance was recorded for 
cotrimaxazole (90%), amoxycillin (88%), ampicillin (73%), tetracycline (65%), cefuroxime and cephalexin 
(40%) each. 
Key words: Staphylococcus aureus, antibiotic susceptibility, prevalence, resistance.  
 
1. INTRODUCTION 
Staphylococcus aureus is a facultative anaerobic Gram-positive coccal bacterium. It is the most common species 
of Staphylococcus to cause Staph infection. Staphylococcus aureus has emerged as one of the mainly important 
human pathogens, and has over the past numerous decades, been a leading foundation of hospital and 
community-acquired infections (Johnssons et al. 2004, Loffler et al.2005, Shittu & Johnson 2006). S. aureus 
may occur as a commensal on skin; it also occurs in the nose frequently (in about a third of the population) 
(Whitt & Salyers 2002) and the throat less commonly. The carriage of Staphylococcus aureus is an important 
source of nosocomial infection and community-acquired methicillin-resistant S. aureus (MRSA). Although S. 
aureus can be present on the skin of the host, a large proportion of its carriage is through the anterior nares of the 
nasal passages. The ability of the nasal passages to harbour S. aureus results from a combination of a weakened 
or defective host immunity and the bacteria's ability to evade host innate immunity (Quinn & Cole 2007). It was 
estimated that 20% of the human population are long-term carriers of S.aureus. This bacterium is a successful 
pathogen due to combination of nasal carriage and bacterial immuno-evasive strategies. One of these strategies is 
the production of carotenoid pigment Kluytmans et al.1997, Murray et al. 2003). S. aureus can cause a range of 
illnesses, from minor skin infections, such as pimples, impetigo, boils (furuncles), cellulitis folliculitis, 
carbuncles, scalded skin syndrome, and abscesses, to life-threatening diseases such as pneumonia, meningitis, 
osteomyelitis, endocarditis, toxic shock syndrome (TSS), bacteremia, and sepsis. Its incidence ranges from skin, 
soft tissue, respiratory, bone, joint, endovascular to wound infections. It is still one of the five most common 
causes of nosocomial infections and is often the cause of post-surgical wound infections (Whitt & Salyers 2002). 
It can survive on domesticated animals, such as dogs, cats, and horses, and can cause bumblefoot in chickens. It 
can survive for hours to weeks, or even months, on dry environmental surfaces, depending on strain (Cimolai 
2008)]. It can host phages, such as Panton-Valentine leukocidin, that increase its virulence. 
S. aureus infections may spread through contact with pus from an infected wound, skin-to-skin contact with an 
infected person by producing hyaluronidase that destroys tissues, and contact with objects such as towels, sheets, 
clothing, or athletic equipment used by an infected person. Various host factors, including loss of the normal 
skin barrier, presence of underlying diseases such as diabetes and acquired immunodeficiency syndrome, or 
defects in neutrophils function predispose to infection. Deeply penetrating S. aureus infections can be severe. 
Prosthetic joints put a person at particular risk for septic arthritis, and staphylococcal endocarditis (infection of 
the heart valves) and pneumonia (Ryan & Ray 2004).  
Drug resistance in microorganisms is a predictable and perhaps inescapable response to the use of antimicrobial 
agent. It can arise from the selection of resistant strains among naturally susceptible species or from the ingress 
of new strains of naturally resistant species. The extent of use of particular agents in a given environment 
dictates the rate at which resistance arises among microbial populations (Kunin et al. 1990). Staphylococcus 
aureus is naturally susceptible to virtually every antibiotic that has ever been developed. Resistance is often 
acquired by horizontal transfer to genes from outside sources, although chromosomal mutation and antibiotic 
selection are also important (Henry & Frank 2010). Infections caused by antibiotic-resistant strains of S. aureus 
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have reached epidemic proportions globally (Grandmann et al. 2006). The overall burden of staphylococcal 
disease particularly that caused by methicillin resistant S. aureus strains (MRSA),is increasing in many 
countries, in both healthcare and community settings (Kaplan et al. 2005). 
The pattern of antimicrobial susceptibility of S. aureus is a worldwide change, especially in developing countries 
making antimicrobial agents increasingly less effective. Thus the present study was carried out to determine the 
prevalence of Staphylococcus aureus in clinical samples and their susceptibility pattern to antibiotics.  
 
2. MATERIALS AND METHODS 
2.1 Study Population 
A total of one hundred and two (102) clinical specimens comprising of wound swabs, nasal swabs, vaginal 
swabs and urine were collected from patients attending Lagos University Teaching Hospital (LUTH), Lagos 
State University Teaching Hospital (LASUTH), and Lagos State University Health Centre. The specimens were 
collected as described by Cheesebrough (2000) and transported to the laboratory within an hour of collection for 
processing. 
2.2 Isolation of Staphylococcus aureus 
 The samples were inoculated on mannitol salt agar (Oxoid) and plates were incubated at 370C for 24 h. Colonies 
formed were later sub-cultured on blood agar twice for purification. The Purified colonies were maintained on 
nutrient agar slant at 40C. 
Identification of Isolates.  
Bacterial isolates were identified on the basis of their colonial morphology, cellular morphology and biochemical 
characteristics following the scheme Barrow & Feltham, (1995) 
2.3 Antibiotic Sensitivity Test 
The agar diffusion method Bauer, et al. (1966) was employed for antimicrobial susceptibility testing. Overnight 
cultures of each isolates were adjusted to 0.5, McFarlannd turbidity standard. A sterile cotton swab was dipped 
into the standardized suspension, drained and used for inoculating 20mL of Mueller-Hinton agar in a 100mm 
disposable plate (Sterilin, UK). The inoculated plates were air –dried, and antibiotic discs (Oxoid, UK) were 
placed on the agar using flamed forceps and were gently pressed down to ensure contact. After proper diffusion 
of the antibiotics into the agar, the plates were now incubated at 370C for 18 h and the zones of inhibition were 
measured and compared with a zone-interpretation chart. The antimicrobial discs used include pefloxacin 
(10µg), ciprofloxacin (20µg), sparfloxacin (20µg), gentamicin (10µg), ampicillin (10µg). erythromycin(10µg) 
azithromycin (15µg), amoxicillin(25µg), cefuroxime (30µg), cephalexin (30µg), cotrimoxazole (30µg), 
tetracycline(15µg) 
 
3. RESULTS 
A total number of 155 clinical specimens were screened for the presence of Staphylococcus aureus, of all the 
cultured samples, only twenty eight (28) showed the presence of these bacteria. The frequency of isolation from 
the various samples examined is shown in Table 1.   
High vaginal swab recorded highest isolation of the Staphylococcus aureus. 
The results of antimicrobial susceptibility pattern of the isolates are illustrated in Table 11. 
 High percentage of sensitivity were obtained for gentamicin (89%,) azithromycin (89%), pefloxacin (79%)  
followed by erythromycin (68%), ciprofloxacin (61%), streptomycin (61%) and sparfloxacin (54%). A high 
resistance was recorded for cotrimaxazole (90%), amoxycillin (88%), ampicillin (73%), tetracycline (65%), 
cefuroxime and cephalexin (40%) each. 
 
4. DISCUSSION 
The isolation of Staphylococci from the clinical specimens is as a result of the widespread nature of this 
organism as earlier reported (Murray et al. 2003).   
The high isolation rate in genital samples (71.4%) might be attributed to the fact that the anatomy of females 
exposes them to easy contamination as this pathogen is endogenous colonizing the vagina vault of healthy 
women (Warner & Onderdonk 2004). This result is similar to the findings of Nkwenlag et al., (Nkwelang et al. 
2009) in which 51% of the genital samples analyzed were positive for Staphylococcus aureus.  
S. aureus is a relatively infrequent urinary tract isolate in the general population. In a multicenter, community-
based study conducted in Great Britain, S. aureus accounted for only 0.5% of isolates (Barrett et al. 1999). A 
similar laboratory-based study conducted in France found that S. aureus accounted for only 1.3% of isolates 
from urine specimens submitted from the community (Goldstein 2000) 
The results obtained in this study are in accordance with these findings which recorded only 5% of isolates from 
the urine samples analysed. Prior studies suggest that isolation of S. aureus from the urine is often secondary to 
staphylococcal bacteremia originating at another site (e.g., in cases of endocarditis) (Musher & McKenzie 1997). 
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Isolation of S. aureus from urine samples in the absence of bacteremia is therefore often considered to represent 
colonization. 
S.aureus has been found to be a frequent cause of wound sepsis (Emmerson 1994).This was seen from the result 
obtained .Though only (7 %) was isolated from the samples, but this could be due to the number analysed. A 
study by Ndip et al., Ndip et al 1997) at Ilorin, Nigeria reported wound infections of 38% as the highest 
frequency of S. aureus isolates   
In specific patient populations, however, S. aureus can be an important primary urinary pathogen. For example, 
MRSA urinary tract infection occurs in both an endemic and epidemic fashion among patients undergoing 
urologic surgical procedures (Bentley et al. 2001, Araki et al. 2002). 
The most effective chemotherapeutic agents observed against Staphylococcus aureus in this study were 
Gentamicin (89%), Azithromycin (89%), Pefloxacin (79%).The isolates are also sensitive to Erythromycin 
(68%)  Ciprofloxacin (61%), Streptomycin (61%), and Sparfloxacin (54%).These results shows that 
staphylococcal infection could be treated with gentamicin, Azithromycin, Pefloxacin, Ciprofloxacin, 
Streptomycin and sparfloxacin. This results is in agreement with the findings of   (Uba & Umar 2002, 
Uwaezuoke & Aririatu 2004) 
Lesser activity were recorded for ampicillin, amoxicillin, cotrimoxazole, tetracycline, cefuroxime and 
cephalexin. The resistance to ampicillin and tetracycline drugs commonly available over the counter in Nigeria 
and very often used without any prescription is due to misuse or abuse of these antibiotics which is a common 
phenomenon in developing countries (Olasupo et al. 2003). 
For a long time, penicillins have been a main stay for the management of a variety of Staphylococcal infections. 
But the organism has gradually acquired resistance towards them. This is observed in this study where only 7%, 
11% of the Staphylococcus aureus were sensitive towards ampicillin and amoxicillin only.  
The  ability of the  of Staphylococcus aureus to resist these antibiotics is as result of their ability to produce a 
plasmid encoded  β-lactamase that hydrolyses the β-lactam ring of this class of antibiotic which is essential for 
its antimicrobial activity. The isolates were found to show 32% sensitivity to tetracycline which is in accordance 
with the result of Oyagade & Oguntoyinbo (1997) and Iroegbu et al 1997), who also found a 32%  and 30.9%  
sensitivity to tetracycline.  
Co-trimoxazole recorded the lowest sensitivity of 7% .This is in contrast to the result of Shammim et al. (2003)  
that recorded 23.6%  sensitivity of  their isolates to co-trimoxazole . 
The high percentage of sensitivity observed to some of the drugs especially gentamicin which is a broad 
spectrum and inexpensive antibiotic shows that its usage has not been abused like others antibiotics observed in 
this study. 
The evolution of increasingly antimicrobial-resistant bacterial species stems from a multitude of factors that 
includes the widespread and sometimes inappropriate use of antimicrobials, the extensive use of these agents as 
growth enhancers in animal feed, and, with the increase in regional and international travel, the relative ease with 
which antimicrobial-resistant bacteria cross geographic barriers (Barrett et al. 1968, Cohen 1992, Tomasz 1994, 
Swartz 1997, Perveen et al. 2013) 
It can be concluded from this study that there is need for regular surveillance on the choice of antibiotic that 
Staphylococcus aureus is susceptible to as this will go a long way in guiding the physician on the management of 
this notorious organism.  
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Table 1: Frequency of Staphylococcus aureus from different clinical specimens  
Specimen  Number examined  Number isolated  
High vagina  80 20(25%) 
Wound  7 2(28.57%) 
Sputum  8 3(37.5%) 
Urine  60  3 
 
 
Table 2:  Antimicrobial susceptibility pattern of the isolates 
Antibiotics  Sensitive  Resistance  
1. Pefloxacin  22 (79%)  6 (21%) 
2.  Ciprofloxacin 17 (61%) 11 (39 %) 
3.  Sparfloxacin  15 (54 %)  13 (46%) 
4.  Gentamicin  25 (89%)  3 (11%) 
5.  Ampicillin  2 (7%)  26 (93%) 
6. Erythromycin  19 (68%)  9 (32%) 
7.  Azithromycin  25 (89%)  3 (11%) 
8.  Amoxycillin 3 (11%)  25 (89%)  
9.  Cefuroxime  12 (43%)  16 (57%)  
10.  Cephalexin  11 (39%) 17 (61%) 
11.  Co-trimoxazole  2 (7%)  26(93%) 
12.  Tetracycline  9 (32%)  19 (68%) 
13. Streptomycin  17 (61%) 11 (39%) 
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